Latest filing published 06 Feb 2023 for Arbutus Biopharma Corporation.
No signal scores available.
This profile gathers the share dealings of William Hugh Collier in Arbutus Biopharma Corporation. Over a trading history stretching from 24 June 2019 to 1 February 2023, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 6 February 2023, reports a share grant in Arbutus Biopharma Corporation. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations